尿素循环在瘤微环境和治疗中的新兴作用
Jiawen Zhou1, Xuan Sun1, Peng Jiang1
1State Key Laboratory of Molecular Oncology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China, 100084.
Trends in cancer
|September 13, 2025
概括
尿素循环 (UC) 对癌症代谢和瘤微环境 (TME) 是至关重要的. 了解UC基因和代谢物改变可以导致更好的癌症疗法,改善患者的治疗结果.
科学领域:
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
- 瘤微环境是一个微环境.
背景情况:
- 尿素循环 (UC) 对于的处理和生物合成至关重要.
- 癌症中普遍存在UC失调,影响细胞代谢和瘤微环境 (TME).
研究的目的:
- 审查UC基因和瘤中的代谢物表达的变化.
- 探索UC在瘤进展,TME和癌症治疗中的作用.
主要方法:
- 关于癌症UC变化的文献综述.
- 分析UC对免疫细胞, stromal 细胞和血管生成的影响.
- 在TME中讨论氨酸和聚胺代谢.
主要成果:
- UC基因和代谢物变化影响瘤进展和TME.
- 该UC影响免疫反应,树皮细胞和血管生成.
- 氨酸和聚胺代谢是TME的关键因素.
结论:
- 准UC,就像阿尔金因剥夺疗法 (ADT) 一样,显示出希望,但面临着像耐药性和毒性这样的挑战.
- 在瘤发生过程中阐明UC酶功能对于有效的个性化癌症疗法至关重要.
- 未来的研究应该优先考虑组合疗法和个性化药物,以提高疗效和患者预后.
相关概念视频
Urea Cycle
49.4K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
49.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K


